A Case Report of Nongerminal Center B-Cell Type Diffuse Large B-Cell Lymphoma Treated to Complete Response with Rituximab and Ibrutinib

Diffuse large B-cell lymphoma (DLBCL) is a molecularly heterogeneous disease consisting of different subtypes with varying clinical behaviors. For example, the activated B-cell-like (ABC) type of DLBCL has lower cure rates with traditional chemotherapy regimens. The molecular pathway promoting tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shouse, Geoffrey, Thinn, Miemie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872664/
https://www.ncbi.nlm.nih.gov/pubmed/29725548
http://dx.doi.org/10.1155/2018/5471368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872664/
https://www.ncbi.nlm.nih.gov/pubmed/29725548
http://dx.doi.org/10.1155/2018/5471368

Ejemplares similares